Russ Stephens is the Vice President of Business for Development for Synexis. Following studies at the University of Georgia and Fribourg University in Geneva, Switzerland, he launched a career in Medical Device and Technology Development. During his 15 years career, Russ has launched several technologies ranging from devices for the treatment of peripheral vascular disease and tumor ablation to stroke and aneurysm treatment. Russ serves on the several Boards supporting technology incubators in the Med device space. Additionally, he is active with numerous legislative efforts supporting physicians and clinicians in their effort to build a progressive healthcare environment.